American Century Companies Inc. bought a new position in Integral Ad Science Holding Corp. (NASDAQ:IAS – Free Report) during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm bought 88,256 shares of the company’s stock, valued at approximately $711,000. American Century Companies Inc. owned 0.05% of Integral Ad Science at the end of the most recent quarter.
Several other hedge funds also recently added to or reduced their stakes in the stock. Vanguard Group Inc. raised its position in Integral Ad Science by 0.5% in the first quarter. Vanguard Group Inc. now owns 9,090,229 shares of the company’s stock valued at $73,267,000 after purchasing an additional 41,683 shares during the period. Aberdeen Group plc grew its stake in shares of Integral Ad Science by 12.7% during the first quarter. Aberdeen Group plc now owns 1,994,980 shares of the company’s stock valued at $16,080,000 after acquiring an additional 224,153 shares in the last quarter. Nuveen Asset Management LLC grew its stake in Integral Ad Science by 0.8% in the fourth quarter. Nuveen Asset Management LLC now owns 1,920,523 shares of the company’s stock worth $20,050,000 after purchasing an additional 15,432 shares in the last quarter. Nuveen LLC acquired a new position in Integral Ad Science in the first quarter worth about $10,897,000. Finally, Invenomic Capital Management LP grew its stake in Integral Ad Science by 52.9% in the fourth quarter. Invenomic Capital Management LP now owns 895,061 shares of the company’s stock worth $9,344,000 after purchasing an additional 309,752 shares in the last quarter. 95.78% of the stock is owned by hedge funds and other institutional investors.
Wall Street Analysts Forecast Growth
IAS has been the subject of a number of research reports. Wall Street Zen upgraded Integral Ad Science from a “hold” rating to a “buy” rating in a research note on Sunday, August 10th. Raymond James Financial cut their price target on Integral Ad Science from $13.00 to $11.00 and set an “outperform” rating on the stock in a report on Friday, August 8th. Stifel Nicolaus lifted their price target on Integral Ad Science from $13.00 to $14.00 and gave the company a “buy” rating in a report on Tuesday, July 22nd. Finally, Barclays boosted their target price on Integral Ad Science from $9.00 to $10.00 and gave the stock an “equal weight” rating in a report on Friday, August 8th. Six analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $13.55.
Integral Ad Science Stock Performance
NASDAQ IAS opened at $8.74 on Friday. The firm’s 50 day moving average price is $8.53 and its two-hundred day moving average price is $8.33. Integral Ad Science Holding Corp. has a twelve month low of $6.26 and a twelve month high of $13.62. The stock has a market cap of $1.45 billion, a price-to-earnings ratio of 25.71, a PEG ratio of 1.29 and a beta of 1.57.
Integral Ad Science (NASDAQ:IAS – Get Free Report) last posted its quarterly earnings results on Thursday, August 7th. The company reported $0.07 EPS for the quarter, beating the consensus estimate of $0.04 by $0.03. Integral Ad Science had a net margin of 9.79% and a return on equity of 5.00%. The business had revenue of $149.20 million for the quarter, compared to analysts’ expectations of $143.02 million. Integral Ad Science has set its Q3 2025 guidance at EPS. FY 2025 guidance at EPS. On average, research analysts forecast that Integral Ad Science Holding Corp. will post 0.26 EPS for the current fiscal year.
Insider Activity
In related news, CEO Lisa Utzschneider sold 9,922 shares of Integral Ad Science stock in a transaction on Wednesday, August 6th. The shares were sold at an average price of $8.12, for a total value of $80,566.64. Following the completion of the sale, the chief executive officer owned 380,557 shares of the company’s stock, valued at approximately $3,090,122.84. The trade was a 2.54% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Over the last three months, insiders have sold 35,073 shares of company stock valued at $289,641. 2.00% of the stock is currently owned by insiders.
Integral Ad Science Profile
Integral Ad Science Holding Corp. operates as a digital advertising verification company in the United States, the United Kingdom, France, Ireland, Germany, Italy, Singapore, Australia, Japan, India, and the Nordics. The company provides IAS Signal, a cloud-based technology platform that offers return on ad spend needs; and deliver independent measurement and verification of digital advertising across devices, channels, and formats, including desktop, mobile, connected TV, social, display, and video.
Featured Articles
- Five stocks we like better than Integral Ad Science
- How Technical Indicators Can Help You Find Oversold StocksÂ
- Affirm Crushes Earnings Expectations, Turns Bears into Believers
- Value Investing: Is it a Good Strategy in 2022? (Hint: Always)
- Analysts See Big Upside for These 3 Retail Stocks
- Where to Find Earnings Call Transcripts
- Buy the Dip? GitLab’s Bullish Case Outweighs the Bears
Receive News & Ratings for Integral Ad Science Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integral Ad Science and related companies with MarketBeat.com's FREE daily email newsletter.